ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Neglected Tropical Diseases Drugs and Vaccine Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-8I10020
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Neglected Tropical Diseases Drugs and Vaccine Market Insights Forecast to 2028
BUY CHAPTERS

Global Neglected Tropical Diseases Drugs and Vaccine Market Research Report 2025

Code: QYRE-Auto-8I10020
Report
July 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
ARTECEF
GlaxoSmithKline PLC
Astrazeneca plc
Novartis
Sanofi Aventis
Ranbaxy Labs
Lupin Ltd
Macleods Pharmaceuticals
Cipla Ltd
Romark Laboratories
Toyama Chemica

Neglected Tropical Diseases Drugs and Vaccine Market Size

The global market for Neglected Tropical Diseases Drugs and Vaccine was valued at US$ 377 million in the year 2024 and is projected to reach a revised size of US$ 514 million by 2031, growing at a CAGR of 4.6% during the forecast period.

Neglected Tropical Diseases Drugs and Vaccine Market

Neglected Tropical Diseases Drugs and Vaccine Market

Neglected tropical diseases (NTDs) are a diverse group of tropical infections which are common in low-income populations in developing regions of Africa, Asia, and the Americas. They are caused by a variety of pathogens such as viruses, bacteria, protozoa and helminths. 
The Neglected Tropical Diseases (NTDs) Drugs and Vaccine Market is driven by the pressing need to combat and eradicate diseases that predominantly affect marginalized and underserved populations in tropical regions. NTDs, which include diseases like malaria, dengue, and schistosomiasis, cause significant morbidity and mortality, making it imperative to develop treatments and vaccines. As global health initiatives and pharmaceutical companies focus on addressing NTDs, the demand for research, development, and access to effective drugs and vaccines continues to grow. However, a key challenge for this market is the need to overcome financial and regulatory hurdles that often hinder investment in NTD research and drug development. Ensuring equitable access to these treatments, addressing drug resistance, and overcoming logistic challenges in delivering vaccines to remote areas are ongoing obstacles. Additionally, the market faces competition from other health priorities and diseases, requiring sustained efforts to mobilize resources and global commitment to eliminate NTDs. Striking a balance between innovation, affordability, and accessibility while addressing the unique challenges of NTDs is crucial for the continued progress of the Neglected Tropical Diseases Drugs and Vaccine Market.
This report aims to provide a comprehensive presentation of the global market for Neglected Tropical Diseases Drugs and Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neglected Tropical Diseases Drugs and Vaccine.
The Neglected Tropical Diseases Drugs and Vaccine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Neglected Tropical Diseases Drugs and Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neglected Tropical Diseases Drugs and Vaccine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Neglected Tropical Diseases Drugs and Vaccine Market Report

Report Metric Details
Report Name Neglected Tropical Diseases Drugs and Vaccine Market
Accounted market size in year US$ 377 million
Forecasted market size in 2031 US$ 514 million
CAGR 4.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Drugs
  • Vaccines
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Artecef BV, GlaxoSmithKline, AstraZeneca, Novartis, Sanofi-Aventis, Ranbaxy Labs, Lupin, Macleods Pharmaceuticals, Cipla, Romark Laboratories, Toyama Chemica
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Neglected Tropical Diseases Drugs and Vaccine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Neglected Tropical Diseases Drugs and Vaccine Market growing?

Ans: The Neglected Tropical Diseases Drugs and Vaccine Market witnessing a CAGR of 4.6% during the forecast period 2025-2031.

What is the Neglected Tropical Diseases Drugs and Vaccine Market size in 2031?

Ans: The Neglected Tropical Diseases Drugs and Vaccine Market size in 2031 will be US$ 514 million.

Who are the main players in the Neglected Tropical Diseases Drugs and Vaccine Market report?

Ans: The main players in the Neglected Tropical Diseases Drugs and Vaccine Market are Artecef BV, GlaxoSmithKline, AstraZeneca, Novartis, Sanofi-Aventis, Ranbaxy Labs, Lupin, Macleods Pharmaceuticals, Cipla, Romark Laboratories, Toyama Chemica

What are the Application segmentation covered in the Neglected Tropical Diseases Drugs and Vaccine Market report?

Ans: The Applications covered in the Neglected Tropical Diseases Drugs and Vaccine Market report are Drugs, Vaccines

What are the Type segmentation covered in the Neglected Tropical Diseases Drugs and Vaccine Market report?

Ans: The Types covered in the Neglected Tropical Diseases Drugs and Vaccine Market report are Malaria, Ebola, Dengue, Chagas, Leishmaniasis, Other

Recommended Reports

Human Infectious Vaccines

Parasitic Disease Treatments

Pediatric & Combination Vaccines

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Malaria
1.2.3 Ebola
1.2.4 Dengue
1.2.5 Chagas
1.2.6 Leishmaniasis
1.2.7 Other
1.3 Market by Application
1.3.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Drugs
1.3.3 Vaccines
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Perspective (2020-2031)
2.2 Global Neglected Tropical Diseases Drugs and Vaccine Growth Trends by Region
2.2.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Neglected Tropical Diseases Drugs and Vaccine Historic Market Size by Region (2020-2025)
2.2.3 Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Region (2026-2031)
2.3 Neglected Tropical Diseases Drugs and Vaccine Market Dynamics
2.3.1 Neglected Tropical Diseases Drugs and Vaccine Industry Trends
2.3.2 Neglected Tropical Diseases Drugs and Vaccine Market Drivers
2.3.3 Neglected Tropical Diseases Drugs and Vaccine Market Challenges
2.3.4 Neglected Tropical Diseases Drugs and Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Revenue
3.1.1 Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Revenue (2020-2025)
3.1.2 Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Players (2020-2025)
3.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Neglected Tropical Diseases Drugs and Vaccine Revenue
3.4 Global Neglected Tropical Diseases Drugs and Vaccine Market Concentration Ratio
3.4.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neglected Tropical Diseases Drugs and Vaccine Revenue in 2024
3.5 Global Key Players of Neglected Tropical Diseases Drugs and Vaccine Head office and Area Served
3.6 Global Key Players of Neglected Tropical Diseases Drugs and Vaccine, Product and Application
3.7 Global Key Players of Neglected Tropical Diseases Drugs and Vaccine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Neglected Tropical Diseases Drugs and Vaccine Breakdown Data by Type
4.1 Global Neglected Tropical Diseases Drugs and Vaccine Historic Market Size by Type (2020-2025)
4.2 Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Type (2026-2031)
5 Neglected Tropical Diseases Drugs and Vaccine Breakdown Data by Application
5.1 Global Neglected Tropical Diseases Drugs and Vaccine Historic Market Size by Application (2020-2025)
5.2 Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Neglected Tropical Diseases Drugs and Vaccine Market Size (2020-2031)
6.2 North America Neglected Tropical Diseases Drugs and Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2020-2025)
6.4 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size (2020-2031)
7.2 Europe Neglected Tropical Diseases Drugs and Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2020-2025)
7.4 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size (2020-2031)
8.2 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2020-2025)
8.4 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size (2020-2031)
9.2 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2020-2025)
9.4 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size (2020-2031)
10.2 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2020-2025)
10.4 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Artecef BV
11.1.1 Artecef BV Company Details
11.1.2 Artecef BV Business Overview
11.1.3 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Introduction
11.1.4 Artecef BV Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2020-2025)
11.1.5 Artecef BV Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Introduction
11.2.4 GlaxoSmithKline Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2020-2025)
11.2.5 GlaxoSmithKline Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Introduction
11.3.4 AstraZeneca Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2020-2025)
11.3.5 AstraZeneca Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Neglected Tropical Diseases Drugs and Vaccine Introduction
11.4.4 Novartis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2020-2025)
11.4.5 Novartis Recent Development
11.5 Sanofi-Aventis
11.5.1 Sanofi-Aventis Company Details
11.5.2 Sanofi-Aventis Business Overview
11.5.3 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Introduction
11.5.4 Sanofi-Aventis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2020-2025)
11.5.5 Sanofi-Aventis Recent Development
11.6 Ranbaxy Labs
11.6.1 Ranbaxy Labs Company Details
11.6.2 Ranbaxy Labs Business Overview
11.6.3 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Introduction
11.6.4 Ranbaxy Labs Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2020-2025)
11.6.5 Ranbaxy Labs Recent Development
11.7 Lupin
11.7.1 Lupin Company Details
11.7.2 Lupin Business Overview
11.7.3 Lupin Neglected Tropical Diseases Drugs and Vaccine Introduction
11.7.4 Lupin Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2020-2025)
11.7.5 Lupin Recent Development
11.8 Macleods Pharmaceuticals
11.8.1 Macleods Pharmaceuticals Company Details
11.8.2 Macleods Pharmaceuticals Business Overview
11.8.3 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Introduction
11.8.4 Macleods Pharmaceuticals Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2020-2025)
11.8.5 Macleods Pharmaceuticals Recent Development
11.9 Cipla
11.9.1 Cipla Company Details
11.9.2 Cipla Business Overview
11.9.3 Cipla Neglected Tropical Diseases Drugs and Vaccine Introduction
11.9.4 Cipla Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2020-2025)
11.9.5 Cipla Recent Development
11.10 Romark Laboratories
11.10.1 Romark Laboratories Company Details
11.10.2 Romark Laboratories Business Overview
11.10.3 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Introduction
11.10.4 Romark Laboratories Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2020-2025)
11.10.5 Romark Laboratories Recent Development
11.11 Toyama Chemica
11.11.1 Toyama Chemica Company Details
11.11.2 Toyama Chemica Business Overview
11.11.3 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Introduction
11.11.4 Toyama Chemica Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2020-2025)
11.11.5 Toyama Chemica Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
ARTECEF
GlaxoSmithKline PLC
Astrazeneca plc
Novartis
Sanofi Aventis
Ranbaxy Labs
Lupin Ltd
Macleods Pharmaceuticals
Cipla Ltd
Romark Laboratories
Toyama Chemica
List of Tables
 Table 1. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Malaria
 Table 3. Key Players of Ebola
 Table 4. Key Players of Dengue
 Table 5. Key Players of Chagas
 Table 6. Key Players of Leishmaniasis
 Table 7. Key Players of Other
 Table 8. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2020-2025) & (US$ Million)
 Table 11. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Region (2020-2025)
 Table 12. Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 13. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Region (2026-2031)
 Table 14. Neglected Tropical Diseases Drugs and Vaccine Market Trends
 Table 15. Neglected Tropical Diseases Drugs and Vaccine Market Drivers
 Table 16. Neglected Tropical Diseases Drugs and Vaccine Market Challenges
 Table 17. Neglected Tropical Diseases Drugs and Vaccine Market Restraints
 Table 18. Global Neglected Tropical Diseases Drugs and Vaccine Revenue by Players (2020-2025) & (US$ Million)
 Table 19. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Players (2020-2025)
 Table 20. Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neglected Tropical Diseases Drugs and Vaccine as of 2024)
 Table 21. Ranking of Global Top Neglected Tropical Diseases Drugs and Vaccine Companies by Revenue (US$ Million) in 2024
 Table 22. Global 5 Largest Players Market Share by Neglected Tropical Diseases Drugs and Vaccine Revenue (CR5 and HHI) & (2020-2025)
 Table 23. Global Key Players of Neglected Tropical Diseases Drugs and Vaccine, Headquarters and Area Served
 Table 24. Global Key Players of Neglected Tropical Diseases Drugs and Vaccine, Product and Application
 Table 25. Global Key Players of Neglected Tropical Diseases Drugs and Vaccine, Date of Enter into This Industry
 Table 26. Mergers & Acquisitions, Expansion Plans
 Table 27. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2020-2025) & (US$ Million)
 Table 28. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Type (2020-2025)
 Table 29. Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 30. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Type (2026-2031)
 Table 31. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2020-2025) & (US$ Million)
 Table 32. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Application (2020-2025)
 Table 33. Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 34. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Application (2026-2031)
 Table 35. North America Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2020-2025) & (US$ Million)
 Table 37. North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2020-2025) & (US$ Million)
 Table 40. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2026-2031) & (US$ Million)
 Table 41. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2020-2025) & (US$ Million)
 Table 43. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2026-2031) & (US$ Million)
 Table 44. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 48. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2020-2025) & (US$ Million)
 Table 49. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2026-2031) & (US$ Million)
 Table 50. Artecef BV Company Details
 Table 51. Artecef BV Business Overview
 Table 52. Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product
 Table 53. Artecef BV Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2020-2025) & (US$ Million)
 Table 54. Artecef BV Recent Development
 Table 55. GlaxoSmithKline Company Details
 Table 56. GlaxoSmithKline Business Overview
 Table 57. GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product
 Table 58. GlaxoSmithKline Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2020-2025) & (US$ Million)
 Table 59. GlaxoSmithKline Recent Development
 Table 60. AstraZeneca Company Details
 Table 61. AstraZeneca Business Overview
 Table 62. AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product
 Table 63. AstraZeneca Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2020-2025) & (US$ Million)
 Table 64. AstraZeneca Recent Development
 Table 65. Novartis Company Details
 Table 66. Novartis Business Overview
 Table 67. Novartis Neglected Tropical Diseases Drugs and Vaccine Product
 Table 68. Novartis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2020-2025) & (US$ Million)
 Table 69. Novartis Recent Development
 Table 70. Sanofi-Aventis Company Details
 Table 71. Sanofi-Aventis Business Overview
 Table 72. Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product
 Table 73. Sanofi-Aventis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2020-2025) & (US$ Million)
 Table 74. Sanofi-Aventis Recent Development
 Table 75. Ranbaxy Labs Company Details
 Table 76. Ranbaxy Labs Business Overview
 Table 77. Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product
 Table 78. Ranbaxy Labs Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2020-2025) & (US$ Million)
 Table 79. Ranbaxy Labs Recent Development
 Table 80. Lupin Company Details
 Table 81. Lupin Business Overview
 Table 82. Lupin Neglected Tropical Diseases Drugs and Vaccine Product
 Table 83. Lupin Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2020-2025) & (US$ Million)
 Table 84. Lupin Recent Development
 Table 85. Macleods Pharmaceuticals Company Details
 Table 86. Macleods Pharmaceuticals Business Overview
 Table 87. Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Product
 Table 88. Macleods Pharmaceuticals Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2020-2025) & (US$ Million)
 Table 89. Macleods Pharmaceuticals Recent Development
 Table 90. Cipla Company Details
 Table 91. Cipla Business Overview
 Table 92. Cipla Neglected Tropical Diseases Drugs and Vaccine Product
 Table 93. Cipla Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2020-2025) & (US$ Million)
 Table 94. Cipla Recent Development
 Table 95. Romark Laboratories Company Details
 Table 96. Romark Laboratories Business Overview
 Table 97. Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product
 Table 98. Romark Laboratories Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2020-2025) & (US$ Million)
 Table 99. Romark Laboratories Recent Development
 Table 100. Toyama Chemica Company Details
 Table 101. Toyama Chemica Business Overview
 Table 102. Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Product
 Table 103. Toyama Chemica Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2020-2025) & (US$ Million)
 Table 104. Toyama Chemica Recent Development
 Table 105. Research Programs/Design for This Report
 Table 106. Key Data Information from Secondary Sources
 Table 107. Key Data Information from Primary Sources
 Table 108. Authors List of This Report


List of Figures
 Figure 1. Neglected Tropical Diseases Drugs and Vaccine Picture
 Figure 2. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Type: 2024 VS 2031
 Figure 4. Malaria Features
 Figure 5. Ebola Features
 Figure 6. Dengue Features
 Figure 7. Chagas Features
 Figure 8. Leishmaniasis Features
 Figure 9. Other Features
 Figure 10. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2020-2031) & (US$ Million)
 Figure 11. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application: 2024 VS 2031
 Figure 12. Drugs Case Studies
 Figure 13. Vaccines Case Studies
 Figure 14. Neglected Tropical Diseases Drugs and Vaccine Report Years Considered
 Figure 15. Global Neglected Tropical Diseases Drugs and Vaccine Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Neglected Tropical Diseases Drugs and Vaccine Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Region: 2024 VS 2031
 Figure 18. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Players in 2024
 Figure 19. Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neglected Tropical Diseases Drugs and Vaccine as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Neglected Tropical Diseases Drugs and Vaccine Revenue in 2024
 Figure 21. North America Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Neglected Tropical Diseases Drugs and Vaccine Market Share by Country (2020-2031)
 Figure 23. United States Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Neglected Tropical Diseases Drugs and Vaccine Market Share by Country (2020-2031)
 Figure 27. Germany Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Share by Region (2020-2031)
 Figure 35. China Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Share by Country (2020-2031)
 Figure 43. Mexico Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Share by Country (2020-2031)
 Figure 47. Turkey Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Artecef BV Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2020-2025)
 Figure 51. GlaxoSmithKline Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2020-2025)
 Figure 52. AstraZeneca Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2020-2025)
 Figure 53. Novartis Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2020-2025)
 Figure 54. Sanofi-Aventis Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2020-2025)
 Figure 55. Ranbaxy Labs Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2020-2025)
 Figure 56. Lupin Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2020-2025)
 Figure 57. Macleods Pharmaceuticals Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2020-2025)
 Figure 58. Cipla Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2020-2025)
 Figure 59. Romark Laboratories Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2020-2025)
 Figure 60. Toyama Chemica Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2020-2025)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Neglected Tropical Disease NTD Treatment Market Research Report 2024
Global Parasitic Diseases Therapeutic Market Insights Forecast to 2030
Neglected Tropical Diseases Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gaucher Disease GD Drugs Market Insights Forecast to 2030
Global Leishmaniasis Treatment Market Insights Forecast to 2030
Global Sexually Transmitted Disease Therapeutics Market Insights Forecast to 2030
Communicable Diseases Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Infectious Disease Drugs Market Insights Forecast to 2030
Global Sleep Movement Disorder Drug Market Insights Forecast to 2030
Global Diagnostic Testing For STDs Market Insights Forecast to 2030
Global Drugs for Central Nervous System Diseases Market Insights Forecast to 2030
Communicable Diseases Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti tuberculosis Therapeutics Market Insights Forecast to 2030
Global Blood Pressure Disorders Drug Market Insights Forecast to 2030
Treatment for Communicable Diseases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global African Trypanosomiasis Treatment Market Research Report 2025
Global Sexually Transmitted Diseases STD Treatment Market Research Report 2024
Global Neurodegenerative Disease Market Insights Forecast to 2030
Global Ectoparasiticides Market Insights Forecast to 2030
Global Diabetic Neurological Disorder Therapeutic Drug Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions